About Us

Cystic Fibrosis (CF) is one of the most common genetic (inherited) diseases in America. It is also one of the most serious. It mainly affects the lungs and the digestive systems in the body, causing breathing problems and problems digesting foods. It is a chronic disease that currently has no cure. 

The CF Center at Stanford is an integrated disease management program that follows patients from diagnosis through adulthood. 

With the current longer life expectancy for patients with Cystic Fibrosis, our clinic population includes patients of all ages. More than half the patients followed by the Stanford CF Center are adults aged 18 years or older.



CF Education Day

March 16, 2019


Pediatric Clinic News

Do you drive away from clinic thinking, "oh no, I forgot to ask a question?" You can now fill out this form ahead of time and bring it to your clinic appointment.  This form is designed to help you get all your questions answered.  This is not mandatory, but a tool to assist you in jogging your memory in preparation for your clinic visit.

Please click here....

PG&E Information

Did you know that you can get assistance with your PG&E bill?  All you need to do is visit the website, print and complete the form with all your medical devices listed.  Then bring your form to your next CF clinic visit, and your provider will sign it. Finally, mail the completed form to PG&E.

Please click here

CF and Dental Health

Oral hygiene (caring for your teeth and gums) can impact CF health.  Here are some guidelines and tips for how to teach and encourage your children to practice good habits to stay happy and healthy.

Please click here for more information...



Adult Clinic News

Adult Support Group

CF Caregivers Support Group

Group Meets Third Tuesday of Every Month.

Two Groups to Choose from:

Parents of children with CF: 5:00 pm - 6:00 pm PST

Parents/Spouses/Partners of Adults with CF: 6:00 pm - 7:00 pm PST

Location: 1st Floor Conference Room, 730 Welch Road, Palo Alto, CA

or Participate by Phone: 1-650-736-4444

Facilitated by Meg Dvorak, LCSW

CFRI Presents:
Research Participation: The Basics and Beyond - Colleen Dunn, RRT, CCRC


Adult Clinic

Adult Clinic

300 Pasteur Drive, 1st Floor, A175

Wednesdays, Thursdays

For New Appointments, call CF Coordinator:


Adult routine appointments

Please call: (650)736-5400

News from the Adult Clinic

Letter from Stanford Adult Team regarding ORKAMBI More 

July 13, 2015

Dear Patient,

As you may already know, Vertex Pharmaceuticals Incorporated has announced that ORKAMBI has been approved by the US Food and Drug Administration.

ORKAMBI is the newest prescription medication used for the treatment of Cystic Fibrosis patients  age 12 years and older and is targeted towards those who have two copies of the F508del mutation in their CFTR gene.  This medication is a combination of Ivacaftor and lumacaftor, and is dispensed in pill form.

The Stanford Adult CF Team is excited about the availability this medication which has shown good promise in decreasing CF exacerbations, and increase in lung function.

We are working now to determine those of our adult patients who qualify to receive ORKAMBI.  We will be happy to discuss this with you at your next clinic visit.

Be advised, if you are eligible for ORKAMBI, you will be required to have a baseline Liver Function test, as well as baseline Spirometry prior to start of drug.  All insurance companies have advised us we will need to submit proof of your genetic mutation, and may in some cases; also require results of your Sweat Chloride. We recognize that for some of you, you may no longer have copies of this, and we are prepared to schedule a repeat Sweat Chloride and/or Genetic Mutation for you if necessary.

Please be patient with us as we work diligently to determine your eligibility for ORKAMBI, and we appreciate your patience as we move forward on this process together.

Best regards,

The Stanford Adult Cystic Fibrosis Team


Pediatric Clinic

Pediatric Clinic

770 Welch Road, Suite 380, 3rd floor

Monday, Tuesday, Wednesday, Friday

For new Pediatric Patients

call: Erica (650)498-2655

Pediatric routine appointments

Please call: (650)724-4788

Nurse Coordinators/Clinic Nurse:

Please call: (650)736-1359

Bone Density (DEXA) (650)723-6855

PFT (full PFT's) (650) 497-8655

Emeryville, Pediatric Clinic

Emeryville, Pediatric Clinic

6121 Hollis Street, Emeryville


For all appointments, please call the nurse coordinator:



Cystic Fibrosis Research

Research is being conducted on the cause, biological mechanisms, new and better form of therapy and, ultimately, the cure for CF is an important part of our CF Center activities. You can be an important part of that research! 

To find out how, call a research coordinator today!
Phone 650-736-0388 or
email us to join the team!

Focus On
Research Participation

Research Participation: A Families Perspective

Richard and Rohini along with their rambunctious one-year-old daughter Ria live in Palo Alto, CA.  Richard is originally from Belfast, Northern Ireland and Rohini is from Topeka, Kansas.  Work brought them to the Bay Area and now they cannot imagine living anywhere else.  On any given weekend you can find this family hiking the Dish, picking up goodies at the local farmers market, or running around Stanford.

Learning of Ria's condition through the newborn testing process Rohini and Richard experienced a whole variety of emotions from confusion to disbelief to anger and eventual acceptance.  They are forever grateful to their family, friends, care team at Stanford, and pediatrician for their love, support, and patience.

Questions and Answers regarding the Research Process

1.  How did you hear about the study?

Our incredible care team including Jackie Zirbes, Julie Matel,  and Zach Sellers all introduced us to this opportunity

2.  What were your concerns regarding enrolling your child in a study?

Our primary concern was the potential side effects that our daughter may face.  It was a matter of understanding the anticipated benefits versus potential risks that helped us to decide to participate in this study.

3.  What would you share with parents of young children who are considering enrolling their child in a study?

No question is too small or insignificant, ask every question that comes to mind.  It can be directly or even peripherally related to the study, all of your questions matter.  And my experience is that the team welcomes any and all questions at any time of day or night.

4.  How would you describe your research experience?

Emotional.  There have been some high highs as we see her stats improve but there have also been some low lows while we try to calm our nearly inconsolable daughter during blood draws.  We would not have been able to get through those low moments without the support of our friends, family, pediatrician, trial care team, and clinic care team.  We feel incredibly grateful for this opportunity and are hopeful that our daughter will be an even stronger, smarter, sassier version of herself at the end of it.

Patient News

Dr. Conrad and Lauren Catron: A Successful Journey to Adult Care

Read Story....